Regenerative Medicine Center
Regenerative Medicine Center
Tianjin, Tianjin Municipality, China7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS | Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, anemia, aplastic anemia, autoimmune disease, autoimmune hemolytic anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, immune system disorder, myelodysplastic syndrome | Recruiting | Not stated | 2026-09-18 | NCT07578675 | |
| Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia | Hemic and Lymphatic Diseases, anemia, autoimmune disease, autoimmune hemolytic anemia, hematologic disorder, hemolytic anemia, immune system disorder | Recruiting | Not stated | 2025-08-05 | NCT06921980 | |
| Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 2 | 2025-08-05 | NCT06224257 | |
| Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia. | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia | Active, not recruiting | Not applicable | 2025-08-05 | NCT05860595 | |
| Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions. | Allergic Transfusion Reaction | Recruiting | Phase 2 | 2025-08-05 | NCT04688736 | |
| CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. | Hemic and Lymphatic Diseases, anemia, autoimmune disease, autoimmune hemolytic anemia, hematologic disorder, hemolytic anemia, immune system disorder | Active, not recruiting | Phase 1 | 2025-05-16 | NCT06231368 | |
| Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy | Gene Therapy; Transfusion-dependent Beta-Thalassemia | Recruiting | Not stated | 2023-08-14 | NCT05991336 |